In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Karl-Heinz Kuck
Speaker
Karl-Heinz Kuck

LANS Cardio, Hamburg (Germany)

Specialities : Atrial Fibrillation , Interventional Cardiology, Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Prof Karl-Heinz Kuck is currently affiliated with LANS Cardio in Hamburg, Germany, as well as the University Heart Center Lübeck in Lübeck, Germany. His main scientific interest since the 1980s has been clinical cardiac electrophysiology, eventually focusing on catheter ablation of various types of atrial, atrioventricular and ventricular tachyarrhythmia. He has been the Principal Investigator of a number of large randomized controlled trials, among them AMICA, ATTEST, BERLIN VT, CASH, CAT, DINAMIT, FIRE AND ICE, and VTACH. In recent years, Prof Kuck has also become actively involved in the field of catheter-based treatment of valvular heart diseases. His scientific activities are reflected (as of November 2019) in more than 800 papers he has authored or co-authored. Prof Kuck has served as a Board Member of the European Heart Rhythm Association (EHRA) and served as EHRA President.

32 presentations from this speaker

... before the second episode - Don't wait for recurrences!

Congress : EHRA 2019

  • Session : Ventricular tachycardia ablation in ischaemic cardiomyopathy - How early and how invasive?
  • Speaker : K Kuck (Hamburg,DE)

Catheter Ablation Can Delay Progression from Paroxysmal To Persistent Atrial Fibrillation

Congress : ESC Congress 2019

  • Session : Late Breaking Science in Atrial Fibrillation 1
  • Speaker : K Kuck (Hamburg,DE)

New technologies for durable pulmonary vein isolation

Congress : ESC Congress 2019

  • Session : New technologies in pulmonary veins isolation for persistent atrial fibrillation
  • Speaker : K Kuck (Hamburg,DE)

An atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment - Conclusion and take home message.

Congress : ESC Congress 2018

  • Session : Atrial fibrillation: from Guidelines to clinical practice
  • Speaker : K Kuck (Hamburg,DE)

Ablation strategy in patients with persistent AF.

Congress : EHRA 2017

  • Session : Establishing a new standard in AF ablation
  • Speaker : K Kuck (Hamburg,DE)
  • Sponsored by Medtronic

Apama Irrigated Multi Electrode RF Balloon Ablation System

Congress : EHRA 2017

  • Session : Innovation Parade
  • Speaker : K Kuck (Hamburg,DE)

Atrial fibrillation ablation: current experience, recent data and new tools

Congress : ESC Congress 2017

  • Session : Most recent developments in atrial fibrillation management
  • Speaker : K Kuck (Hamburg,DE)

Cryo ablation in persistent atrial fibrillation: where do we stand?

Congress : EHRA 2017

  • Session : Keep cool: expert approaches for atrial fibrillation cryo ablation
  • Speaker : K Kuck (Hamburg,DE)

Identification of successful ablation sites: AP potentials and other criteria.

Congress : EHRA 2017

  • Session : WPW Syndromes revisited: from the ECG to AP-potentials
  • Speaker : K Kuck (Hamburg,DE)

Multicentre trial of a transfemoral mitral valve reconstruction system

Congress : Heart Failure 2017

  • Session : Rapid Fire 4 - Therapy and management
  • Speaker : K Kuck (Hamburg,DE)

Strategies, techniques, and endpoints.

Congress : EHRA 2017

  • Session : Atrial fibrillation ablation update, joint document with HRS
  • Speaker : K Kuck (Hamburg,DE)

Transcatheter mitral valve repair: keys for success.

Congress : ESC Congress 2017

  • Session : Transcatheter mitral valve repair therapy: adding life to years... And more!
  • Speaker : K Kuck (Hamburg,DE)
  • Sponsored by Abbott Vascular

Cryoballoon ablation is changing the landscape for AF ablation.

Congress : ESC Congress 2016

  • Session : Creating a new landscape in AF ablation and the impact on clinical practice
  • Speaker : K Kuck (Hamburg,DE)
  • Sponsored by Medtronic

Up to 1-year follow-up results from a multi-centre trial of a novel percutaneous mitral annuloplasty system

Congress : ESC Congress 2016

  • Session : Atrio-ventricular valve intervention
  • Speaker : K Kuck (Hamburg,DE)

A new era for atrial fibrillation ablation: rationale of the FIRE and ICE study.

Congress : ESC Congress 2015

  • Session : Finding the holy grail of Atrial Fibrillation (AF) ablation
  • Speaker : K Kuck (Hamburg,DE)
  • Sponsored by Medtronic

Can catheter ablation of ventricular tachyarrhythmias prevent sudden cardiac death?

Congress : ESC Congress 2015

  • Session : Life-threatening ventricular arrhythmias: where do we stand in 2015?
  • Speaker : K Kuck (Hamburg,DE)
  • ESC and the Saudi Heart Association

Conclusions and discussion.

Congress : EHRA 2015

  • Session : Improving outcomes in Paroxysmal and Persistent AF Ablation
  • Speaker : K Kuck (Hamburg,DE)
  • Sponsored by Medtronic

Introduction.

Congress : EHRA 2015

  • Session : How to optimise the mitral regurgitation treatment of your heart failure patients with TMVR?
  • Speaker : K Kuck (Hamburg,DE)
  • Sponsored by Abbott Vascular

Opening Address.

Congress : EHRA 2015

  • Session : Inaugural session
  • Speaker : K Kuck (Hamburg,DE)

Percutaneous annuloplasty for mitral valve repair multicentre trial result

Congress : Heart Failure 2015

  • Session : Late Breaking Trials I: Therapies for acute and advanced heart failure
  • Speaker : K Kuck (Hamburg,DE)

Take home messages.

Congress : EHRA 2015

  • Session : How to optimise the mitral regurgitation treatment of your heart failure patients with TMVR?
  • Speaker : K Kuck (Hamburg,DE)
  • Sponsored by Abbott Vascular

Ventricular tachycardias and ventricular fibrillation in structurally normal hearts.

Congress : ESC Congress 2015

  • Session : ESC Guidelines - Ventricular Arrhythmias & Sudden Cardiac Death
  • Speaker : K Kuck (Hamburg,DE)

Welcome address by the EHRA President

Congress : EHRA 2015

  • Session : Inaugural session
  • Speaker : K Kuck (Hamburg,DE)

AMIO-CAT: Discussant review.

Congress : ESC Congress 2014

  • Session : Hot Line: Coronary artery disease and atrial fibrillation
  • Speaker : K Kuck (Hamburg,DE)

Electrophysiology procedures.

Congress : ESC Congress 2014

  • Session : Innovation in interventional imaging
  • Speaker : K Kuck (Hamburg,DE)

Left appendage closure is an alternative to anticoagulants in atrial fibrillation patients. CONCLUSION.

Congress : ESC Congress 2014

  • Session : Debate about innovative strategies in electrophysiology
  • Speaker : K Kuck (Hamburg,DE)

Review of 2012 Guidelines and overview of atrial fibrillation patient types.

Congress : ESC Congress 2014

  • Session : Rhythm management of the atrial fibrillation patient: practical implementation of the 2012 ESC Guidelines
  • Speaker : K Kuck (Hamburg,DE)
  • Organised by Asklepios Klinik St Georg / Course Director: Karl-Heinz Kuck / Supported by an unrestricted educational grant from Biosense Webster

Summary of the key learnings from discussion.

Congress : ESC Congress 2014

  • Session : Rhythm management of the atrial fibrillation patient: practical implementation of the 2012 ESC Guidelines
  • Speaker : K Kuck (Hamburg,DE)
  • Organised by Asklepios Klinik St Georg / Course Director: Karl-Heinz Kuck / Supported by an unrestricted educational grant from Biosense Webster

Who should you refer for percutaneous mitral valve repair?

Congress : ESC Congress 2014

  • Session : Treating mitral regurgitation with percutaneous mitral valve repair: when the multidisciplinary team is key
  • Speaker : K Kuck (Hamburg,DE)
  • Sponsored by Abbott Vascular

Importance and impact of the European electrophysiology community.

Congress : ESC Congress 2013

  • Session : EHRA 2013 summits and scientific consensus statements
  • Speaker : K Kuck (Hamburg,DE)

Repetitive monomorphic ventricular extrasystoles. Can I recognise the dangerous ones?

Congress : ESC Congress 2013

  • Session : Ventricular extrasystoles. Just an ugly electrocardiogram or a threatening burden?
  • Speaker : K Kuck (Hamburg,DE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are